STOCKHOLM, April 10, 2018 /PRNewswire/ -- Moberg Pharma´s Annual Report for 2017 has been published and is available on www.mobergpharma.com
About this information
Moberg Pharma AB is obliged to make this information public pursuant to the EU Market Abuse Regulation (MAR). The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. (CET) on April 10th, 2018.
For more information, please contact:
Peter Wolpert
CEO
phone: +1-908-432-22-03 (US)
+46-70-735-71-35
e-mail: peter.wolpert@mobergpharma.se
Anna Ljung,
CFO
phone: +46-70-766-60-30
e-mail: anna.ljung@mobergpharma.se
This information was brought to you by Cision http://news.cision.com
http://news.cision.com/moberg-pharma/r/moberg-pharma-annual-report-2017,c2490385
The following files are available for download:
| Moberg Pharma Annual Report 2017 |
View original content:http://www.prnewswire.com/news-releases/moberg-pharma-annual-report-2017-300627023.html
SOURCE Moberg Pharma